-
-
-
-
-
-
-
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
-
-
-
-
-
-
Wave Life Sciences to Present at Jefferies London Healthcare Conference
-
-
-
-
-
-
-
Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
-
-
-
-
-
-
-
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
-
-
-
-
-
-
-
Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares
-
-
-
-
-
-
-
Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference
-
-
-
-
-
-
-
WAVE Life Sciences (WVE) Commences Offering of Ordinary Shares
-
72,485 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

